Browse press releases
The newest releases come first, each with its full text here and a link to its original. Try the filters to narrow them down.
- Methanex Provides Update on New Zealand OperationsMethanex Corporation (the “Company” or “Methanex”) (TSX: MX) (Nasdaq: MEOH) announced today that it has entered into an agreement to sell substantially all of its New Zealand natural gas contractual entitlements commencing in the first quarter of 2027 and continuing through the end of the decade when such entitlements expire. Given the continued decline in domestic natural gas availability and the lack of a clear pathway to meaningful new supply, Methanex has determined that continued operations in New Zealand are not sustainable and as such has taken steps to optimize value from its remaining New Zealand gas position. As a result of this agreement, the Company expects to indefinitely idle its New Zealand production facilities during the first quarter of 2027 and will work closely with employees, contractors, suppliers, customers and government stakeholders during this transition period.
- Royale Energy Reports Current SEC Status and Resumed TradingRoyale Energy, Inc. (OTC: ROYL) (“Royale” or the “Company”) today announced that it is current with its SEC reporting obligations, trading of its common stock has resumed on the OTC Pink market, and the Company has initiated the application process for quotation on the OTCQB® Venture Market.
- Xos Hub Surpasses One Gigawatt-Hour of Energy Delivered in the FieldXos Hub Surpasses One Gigawatt-Hour of Energy Delivered in the Field
- Kaplan Fox & Kilsheimer LLPKaplan Fox Alerts Investors of Bloom Energy Corporation (BE) to an Upcoming Deadline of September 28, 2026 in the Securities Class ActionKaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Bloom Energy Corporation ("Bloom Energy" or the "Company") (NYSE: BE) on behalf of investors that purchased or otherwise acquired Bloom Energy securities between February 27, 2025 and July 8, 2026 (the "Class Period").CLICK HERE TO JOIN THE CASEIf you are an investor in Bloom Energy and have suffered losses, you may CLICK HERE to contact us. You may...
- Shufti Ranks #1 in G2 Fall 2026 Grid® Report for Identity Verification and AML, Earns 40+ Badges Across 12 CategoriesShufti ranks #1 in G2’s Fall 2026 Identity Verification Grid® and earns 40+ badges across 12 categories, including AML, address, and fraud detection.
- Energy Vault Holdings, Inc.Energy Vault’s 100 MW AI Infrastructure Project in Sardinia Receives Italian Government Designation as Project of Pre-Eminent National Strategic InterestWESTLAKE VILLAGE, Calif., September 01, 2026--Energy Vault Holdings, Inc. (NYSE: NRGV) ("Energy Vault" or the "Company"), a global energy infrastructure company supporting grid reliability and next-generation AI and high-performance computing infrastructure, today announced that the Italian Council of Ministers has designated the Digital Vault Sulcis investment program as being of pre-eminent national strategic interest, on the proposal of Minister of Enterprises and Made in Italy Adolfo Urso, a
- Jarrow FormulasJarrow Formulas® Launches Gut & Protein Optimizer and NMN 300 mg to Support Protein Absorption, Cellular Energy and Healthy AgingNew formulas designed to help consumers with proactive long-term health — Jarrow Formulas®, a leading formulator and supplier of science-backed nutritional supplements, today announced the launch of two new products, expanding its...
- Rigaku Launches CT Lab HR160 High-Resolution X-ray CT SystemTOKYO, September 01, 2026--Rigaku Corporation, a global solutions partner in X-ray analytical systems and a group company of Rigaku Holdings Corporation (Headquarters: Akishima, Tokyo; President and CEO: Jun Kawakami; "Rigaku"), today announced the launch of the CT Lab HR160, a high-resolution X-ray computed tomography (CT) system for battery, semiconductor devices, electronic components, and advanced materials analysis. The system is developed in collaboration with Excillum AB, the global sourc
- Cornerstone Robotics Announces Strategic Partnership with Medtronic to Expand Global Access to Robotic-assisted SurgeryCompanies: Medtronic plcHONG KONG, Sep 1, 2026 - Cornerstone Robotics, an innovative surgical robotics company founded and headquartered in Hong Kong, today announced a strategic partnership with Medtronic (NYSE: MDT), a global leader in healthcare technology. As part of the partnership, Medtronic will make an approximately US$700 million strategic investment in Cornerstone Robotics and have rights to distribute Cornerstone Robotics’ SentireTM surgical system in select markets outside the U.S. where the system is market approved. A Shared Vision: Bridging the Global Access Gap in Minimally Invasive Care With robotic-assisted surgery adoption still in single digits globally, the opportunity to make advanced surgical care accessible to more patients, physicians, and health systems around the world is significant. Addressing this market requires both continuous technical innovation and strong market scaling capabilities. By aligning Cornerstone Robotics’ technology with Medtronic’s comprehensive global presence, the two companies aim to make high-quality robotic-assisted surgery accessible to more patients worldwide. A Strategic Alignment: Scaling Technology Solutions to Reach More Patients Cornerstone Robotics has established a strong strategic foundation through its full-stack in-house R&D and vertically integrated paradigm. By independently developing its core hardware, control software, advanced algorithms, and proprietary imaging and energy platforms, Cornerstone Robotics maintains substantial control over product integration, quality, and supply chain resilience. This underpins the exceptional stability and high-fidelity performance of the Sentire surgical system in demanding clinical environments. In 2024, Cornerstone Robotics’ Sentire surgical system received National Medical Products Administration approval in China. In May 2026, Sentire surgical system received CE Mark in the European Union and approval from Singapore Health Sciences Authority, both covering minimally invasive general, gynecologic, thoracic, and urologic surgical procedures. “This partnership marks an important step in advancing access to robotic-assisted surgery around the world,” said Professor Kwok Wai Samuel AU, Founder and CEO of Cornerstone Robotics. “There remains a significant gap between the growing demand for minimally invasive surgery and the availability of robotic-assisted surgical technologies. At Cornerstone Robotics, we have built a strong foundation through full-stack in-house R&D and vertical integration, enabling us to continuously advance the core technologies of surgical robotics. Our partnership with Medtronic positions us to further accelerate and scale our work to bring the benefits of robotic-assisted surgery to more surgeons and patients around the world.” “This investment and distribution agreement strengthens Medtronic’s ability to further expand access to minimally invasive surgery to more patients around the world. We’re excited to bring more choice in robotics, and Sentire is a strong complement to our Hugo platform," said Matt Anderson, Senior Vice President and President, Surgical at Medtronic. The partnership marks a significant milestone for both companies to collaboratively advance their shared mission of making robotic-assisted surgery more accessible worldwide. Advisors Kirkland & Ellis and Global Law Office are acting as legal counsel to Cornerstone Robotics. Morgan Stanley & Co. LLC is serving as exclusive financial advisor to Medtronic, and Cleary Gottlieb Steen & Hamilton LLP is serving as lead legal counsel. About Cornerstone Robotics Founded and headquartered in Hong Kong, Cornerstone Robotics is an innovative surgical robotics company driven by the vision of leading medical innovations for a healthier world. We advance surgical care with cutting-edge robotic systems that make high-quality healthcare more accessible and efficient globally. With three global R&D hubs and six business centres worldwide, Cornerstone Robotics has established a 30,000-square-meter manufacturing facility in China. Developed entirely in-house, our SentireTM surgical system has completed multi-specialty clinical trials and received market approval across China, the European Union and Singapore, advancing high-quality surgical care worldwide. To find out more information, please visit https://en.csrbtx.com/ and follow us on LinkedIn. About Medtronic Bold thinking. Bolder actions. We are Medtronic. Medtronic plc, headquartered in Galway, Ireland, is the leading global healthcare technology company that boldly attacks the most challenging health problems facing humanity by searching out and finding solutions. Our Mission — to alleviate pain, restore health, and extend life — unites a global team of 95,000+ passionate people across more than 150 countries. Our technologies and therapies treat 70 health conditions and include cardiac devices, surgical robotics, insulin pumps, surgical tools, patient monitoring systems, and more. Powered by our diverse knowledge, insatiable curiosity, and desire to help all those who need it, we deliver innovative technologies that transform the lives of two people every second, every hour, every day. Expect more from us as we empower insight-driven care, experiences that put people first, and better outcomes for our world. In everything we do, we are engineering the extraordinary. For more information on Medtronic, visit www.Medtronic.com and follow on LinkedIn.
- Cornerstone Robotics Announces Strategic Partnership with Medtronic to Expand Global Access to Robotic-assisted SurgeryCompanies: Medtronic plcHONG KONG, Sep 1, 2026 - Cornerstone Robotics, an innovative surgical robotics company founded and headquartered in Hong Kong, today announced a strategic partnership with Medtronic (NYSE: MDT), a global leader in healthcare technology. As part of the partnership, Medtronic will make an approximately US$700 million strategic investment in Cornerstone Robotics and have rights to distribute Cornerstone Robotics’ SentireTM surgical system in select markets outside the U.S. where the system is market approved. A Shared Vision: Bridging the Global Access Gap in Minimally Invasive Care With robotic-assisted surgery adoption still in single digits globally, the opportunity to make advanced surgical care accessible to more patients, physicians, and health systems around the world is significant. Addressing this market requires both continuous technical innovation and strong market scaling capabilities. By aligning Cornerstone Robotics’ technology with Medtronic’s comprehensive global presence, the two companies aim to make high-quality robotic-assisted surgery accessible to more patients worldwide. A Strategic Alignment: Scaling Technology Solutions to Reach More Patients Cornerstone Robotics has established a strong strategic foundation through its full-stack in-house R&D and vertically integrated paradigm. By independently developing its core hardware, control software, advanced algorithms, and proprietary imaging and energy platforms, Cornerstone Robotics maintains substantial control over product integration, quality, and supply chain resilience. This underpins the exceptional stability and high-fidelity performance of the Sentire surgical system in demanding clinical environments. In 2024, Cornerstone Robotics’ Sentire surgical system received National Medical Products Administration approval in China. In May 2026, Sentire surgical system received CE Mark in the European Union and approval from Singapore Health Sciences Authority, both covering minimally invasive general, gynecologic, thoracic, and urologic surgical procedures. “This partnership marks an important step in advancing access to robotic-assisted surgery around the world,” said Professor Kwok Wai Samuel AU, Founder and CEO of Cornerstone Robotics. “There remains a significant gap between the growing demand for minimally invasive surgery and the availability of robotic-assisted surgical technologies. At Cornerstone Robotics, we have built a strong foundation through full-stack in-house R&D and vertical integration, enabling us to continuously advance the core technologies of surgical robotics. Our partnership with Medtronic positions us to further accelerate and scale our work to bring the benefits of robotic-assisted surgery to more surgeons and patients around the world.” “This investment and distribution agreement strengthens Medtronic’s ability to further expand access to minimally invasive surgery to more patients around the world. We’re excited to bring more choice in robotics, and Sentire is a strong complement to our Hugo platform," said Matt Anderson, Senior Vice President and President, Surgical at Medtronic. The partnership marks a significant milestone for both companies to collaboratively advance their shared mission of making robotic-assisted surgery more accessible worldwide. Advisors Kirkland & Ellis and Global Law Office are acting as legal counsel to Cornerstone Robotics. Morgan Stanley & Co. LLC is serving as exclusive financial advisor to Medtronic, and Cleary Gottlieb Steen & Hamilton LLP is serving as lead legal counsel. About Cornerstone Robotics Founded and headquartered in Hong Kong, Cornerstone Robotics is an innovative surgical robotics company driven by the vision of leading medical innovations for a healthier world. We advance surgical care with cutting-edge robotic systems that make high-quality healthcare more accessible and efficient globally. With three global R&D hubs and six business centres worldwide, Cornerstone Robotics has established a 30,000-square-meter manufacturing facility in China. Developed entirely in-house, our SentireTM surgical system has completed multi-specialty clinical trials and received market approval across China, the European Union and Singapore, advancing high-quality surgical care worldwide. To find out more information, please visit https://en.csrbtx.com/ and follow us on LinkedIn. About Medtronic Bold thinking. Bolder actions. We are Medtronic. Medtronic plc, headquartered in Galway, Ireland, is the leading global healthcare technology company that boldly attacks the most challenging health problems facing humanity by searching out and finding solutions. Our Mission — to alleviate pain, restore health, and extend life — unites a global team of 95,000+ passionate people across more than 150 countries. Our technologies and therapies treat 70 health conditions and include cardiac devices, surgical robotics, insulin pumps, surgical tools, patient monitoring systems, and more. Powered by our diverse knowledge, insatiable curiosity, and desire to help all those who need it, we deliver innovative technologies that transform the lives of two people every second, every hour, every day. Expect more from us as we empower insight-driven care, experiences that put people first, and better outcomes for our world. In everything we do, we are engineering the extraordinary. For more information on Medtronic, visit www.Medtronic.com and follow on LinkedIn.
- Fervo Energy与谷歌签署396兆瓦购电协议格隆汇9月1日｜美国地热能源公司FervoEnergy与谷歌(GOOG.US)签署396兆瓦购电协议。FervoEnergy表示，谷歌将购买无碳能源，旨在为在犹他州可能建设的数据中心提供基础能源支持。将为谷歌提供一项选择权，使其可在2030年6月之前将购电协议规模扩大600兆瓦，总计达到近1吉瓦。
- Chesapeake Utilities CorporationChesapeake Utilities Corporation Announces Sale of 49% Ownership Interest in Florida Energy Pathway ProjectNextEra Energy Resources to acquire a minority interest in landmark South Florida natural gas infrastructure project. — Chesapeake Utilities Corporation (NYSE: CPK), through its indirect subsidiary Peninsula Pipeline Holdings, LLC ("Peninsula"),...